| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $1.27B | +18.6% |
| Cost of Revenue | $330.1M | +11.3% |
| Gross Profit | $937.2M | +21.3% |
| R&D Expense | $342.0M | +9.1% |
| SG&A Expense | $160.6M | +12.1% |
| Operating Income | -$129.9M | +40.7% |
| Interest Expense | $26.1M | +3.9% |
| Pre-tax Income | -$122.8M | +43.4% |
| Income Tax | -$184.5M |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $540.4M | -16.1% |
| Accounts Receivable | $323.0M | +23.8% |
| Current Assets | $1.53B | +20.1% |
| Total Assets | $2.24B | +28.6% |
| Current Liabilities | $871.1M | +21.6% |
| Long-term Debt | $568.6M | +0.2% |
| Total Liabilities | $1.50B | +11.9% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $148.8M | +317.1% |
| Capital Expenditures | $3.5M | +28.5% |
| Investing Cash Flow | -$288.0M | -5.5% |
| Financing Cash Flow | $40.1M | +129.3% |
| Free Cash Flow | $145.3M | +340.6% |
| -1056.6% |
| Net Income | $61.7M | +126.1% |
| EPS (Basic) | $0.62 | +125.1% |
| EPS (Diluted) | $0.59 | +123.9% |
| Stockholders' Equity |
| $738.2M |
| +85.1% |